RXO.NYSERxo, INC

SCHEDULE: Finepoint Capital Discloses 5.7% Stake in RXO Inc.

Sentiment:

Beneficial Ownership Disclosure


Finepoint Capital LP and Herbert Wagner have reported a 5.7% beneficial ownership stake in RXO, Inc., totaling 9,388,789 shares.

Summary

  • Finepoint Capital LP and Herbert Wagner jointly reported beneficial ownership of 9,388,789 shares of RXO, Inc. Common Stock.
  • This ownership represents 5.7% of RXO, Inc.'s outstanding Common Stock.
  • The percentage ownership is calculated based on 164,111,872 shares outstanding as of November 4, 2025, as reported in RXO, Inc.'s Form 10-Q for the period ended September 30, 2025.
  • Finepoint Capital LP is a Delaware limited partnership and a registered investment adviser, while Herbert Wagner is its founder and managing partner.
  • The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of RXO, Inc.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral disclosure, as Schedule 13G filings are routine reports of passive beneficial ownership and do not typically contain performance-related information or suggest a change in company operations.

Positives

  • The disclosure of a significant institutional stake by Finepoint Capital LP and Herbert Wagner provides transparency into the company's ownership structure.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance from RXO, Inc. or the reporting persons regarding the issuer's future performance.

Industry Context

StockSavvy.ai notes that institutional filings like this provide transparency into significant ownership stakes, which can offer insights into investor confidence and potentially influence market perception of a stock, although this specific filing indicates a passive investment intent.

Stakeholder Impact

  • Shareholders: Provides increased transparency regarding significant institutional ownership in RXO, Inc.

Key Dates

DateDescription
2025-09-30End of the period for RXO, Inc.'s Form 10-Q, which reported shares outstanding.
2025-11-04Date as of which 164,111,872 shares of RXO, Inc. Common Stock were outstanding.
2025-11-06Date RXO, Inc. filed its Form 10-Q for the period ended September 30, 2025, with the SEC.
2025-12-31Date of the event that required the filing of this Schedule 13G.
2026-02-13Date the Schedule 13G was signed and filed by Finepoint Capital LP and Herbert Wagner.

Keywords

RXO, Finepoint Capital, Herbert Wagner, Schedule 13G, beneficial ownership, common stock, investment adviser, institutional ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.